Skip to main content

GLD 40 Pill - beige capsule/oblong, 18mm

Generic Name: doxycycline

Pill with imprint GLD 40 is Beige, Capsule/Oblong and has been identified as Oracea 40 mg (immediate release 30 mg / delayed release 10 mg). It is supplied by Galderma Laboratories LP.

Oracea is used in the treatment of Gonococcal Infection, Uncomplicated; Ocular Rosacea; Rosacea; Cervicitis; Chancroid and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Oracea 40 mg (immediate release 30 mg / delayed release 10 mg) is not a controlled substance under the Controlled Substances Act (CSA).

Images for GLD 40

Oracea 40 mg (immediate release 30 mg / delayed release 10 mg) GLD 40
Oracea 40 mg (immediate release 30 mg / delayed release 10 mg) GLD 40
Oracea 40 mg (immediate release 30 mg / delayed release 10 mg) GLD 40

Oracea

Generic Name
doxycycline
Imprint
GLD 40
Strength
40 mg (immediate release 30 mg / delayed release 10 mg)
Color
Beige
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Miscellaneous antimalarials, Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Galderma Laboratories LP
Inactive Ingredients
hypromelloses, ferric oxide red, ferric oxide yellow, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, polysorbate 80, sucrose, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00299-3822 Galderma Laboratories, L.P.
66993-0815 Prasco Laboratories
54868-5676 (Discontinued) Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Related images for "GLD 40"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.